EVs from BALF-Mediators of Inflammation and Potential Biomarkers in Lung Diseases

被引:29
|
作者
Zareba, Lukasz [1 ]
Szymanski, Jacek [1 ,2 ]
Homoncik, Zuzanna [1 ]
Czystowska-Kuzmicz, Malgorzata [1 ]
机构
[1] Med Univ Warsaw, Chair & Dept Biochem, Banacha 1, PL-02097 Warsaw, Poland
[2] Warsaw Univ Technol, Fac Chem, Noakowskiego 3, PL-00664 Warsaw, Poland
关键词
extracellular vesicles (EVs); bronchoalveolar lavage fluid (BALF); inflammatory lung diseases; lung cancer; exosomes; biomarker;
D O I
10.3390/ijms22073651
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extracellular vesicles (EVs) have been identified as key messengers of intracellular communication in health and disease, including the lung. EVs that can be found in bronchoalveolar lavage fluid (BALF) are released by multiple cells of the airways including bronchial epithelial cells, endothelial cells, alveolar macrophages, and other immune cells, and they have been shown to mediate proinflammatory signals in many inflammatory lung diseases. They transfer complex molecular cargo, including proteins, cytokines, lipids, and nucleic acids such as microRNA, between structural cells such as pulmonary epithelial cells and innate immune cells such as alveolar macrophages, shaping mutually their functions and affecting the alveolar microenvironment homeostasis. Here, we discuss this distinct molecular cargo of BALF-EVs in the context of inducing and propagating inflammatory responses in particular acute and chronic lung disorders. We present different identified cellular interactions in the inflammatory lung via EVs and their role in lung pathogenesis. We also summarize the latest studies on the potential use of BALF-EVs as diagnostic and prognostic biomarkers of lung diseases, especially of lung cancer.
引用
收藏
页数:26
相关论文
共 50 条
  • [1] Isoprostanes, emerging biomarkers and potential mediators in cardiovascular diseases
    Cracowski, JL
    Ormezzano, O
    EUROPEAN HEART JOURNAL, 2004, 25 (19) : 1675 - 1678
  • [2] Potential of upper airway mediators as biomarkers for asthmatic lung
    Zissler, U. M.
    Ulrich, M.
    Jakwerth, C. A.
    Bahmer, T.
    Weckmann, M.
    Schmidt-Weber, C. B.
    Chaker, A. M.
    ALLERGY, 2018, 73 : 200 - 200
  • [3] Mediators of Inflammation and Angiogenesis in Chronic Spontaneous Urticaria: Are They Potential Biomarkers of the Disease?
    Puxeddu, Ilaria
    Pratesi, Federico
    Ribatti, Domenico
    Migliorini, Paola
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [4] Mediators of Inflammation - A Potential Source of Biomarkers in Oral Squamous Cell Carcinoma
    Tampa, Mircea
    Mitran, Madalina Irina
    Mitran, Cristina Iulia
    Sarbu, Maria Isabela
    Matei, Clara
    Nicolae, Ilinca
    Caruntu, Ana
    Tocut, Sandra Milena
    Popa, Mircea Ioan
    Caruntu, Constantin
    Georgescu, Simona Roxana
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [5] The roles of miRNAs as potential biomarkers in lung diseases
    Alipoor, Shamila D.
    Adcock, Ian M.
    Garssen, Johan
    Mortaz, Esmaeil
    Varahram, Mohammad
    Mirsaeidi, Mehdi
    Velayati, Aliakbar
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 791 : 395 - 404
  • [6] Lymphocyte profile in the BALF from affected lung in comparison to healthy lung and systemic inflammation in lung cancer
    Osinska, Iwona
    Stelmaszczyk-Emmel, Anna
    Polubiec-Kownacka, Malgorzata
    Dziedzic, Dariusz
    Domagala-Kulawik, Joanna
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [7] MicroRNA: Biogenesis and potential role as biomarkers in lung diseases
    Verma, Amit K.
    Goyal, Yamini
    Bhatt, Deepti
    Dev, Kapil
    Beg, Mirza Masroor Ali
    META GENE, 2021, 29
  • [8] Exosome-Derived Mediators as Potential Biomarkers for Cardiovascular Diseases: A Network Approach
    Moreira-Costa, Liliana
    Barros, Antonio S.
    Lourenco, Andre P.
    Leite-Moreira, Adelino F.
    Nogueira-Ferreira, Rita
    Thongboonkerd, Visith
    Vitorino, Rui
    PROTEOMES, 2021, 9 (01) : 1 - 29
  • [9] Inflammation, ageing and diseases of the lung: Potential therapeutic strategies from shared biological pathways
    Faniyi, Aduragbemi A.
    Hughes, Michael J.
    Scott, Aaron
    Belchamber, Kylie B. R.
    Sapey, Elizabeth
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (09) : 1790 - 1807
  • [10] MicroRNAs in Cerebrovascular Diseases - from Pathophysiology to Potential Biomarkers
    Volny, O.
    Kasickova, L.
    Coufalova, D.
    Cimflova, P.
    Novak, J.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2016, 79 (03) : 287 - 293